NSE: ABBOTINDIA | BSE: 500488

Expensive Performer

Download real time

29077.40 -831.90 (-2.78%)

9,754 NSE+BSE Volume

NSE 04 Apr, 2025 3:31 PM (IST)

61,787.4

Market Cap

High in industry

0.4

Beta 1Year

Very Low volatility

Abbott India Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for ABBOTINDIA, BSE:500488 Abbott India Ltd.

Abbott India Ltd.

13 Nov 2023

29077.40

-2.78%

Result Update:Abbott India

Hold: Abbott India Ltd.

Axis Direct

Abbott India is growing 1.6 to 1.8 times faster than IPM, based on high brand recognition and an excellent product portfolio.. We have a Hold on the stock.

Abbott India Ltd. is trading below its 30 day SMA of 30284.4

Abbott India Ltd.

11 Aug 2023

29077.40

-2.78%

Result Update:Abbott India

Hold: Abbott India Ltd.

Target

Axis Direct

Company Outlook & Guidance: Abbott India is growing 1.6 to 1.8 times faster than IPM, based on high brand recognition and an excellent product portfolio. Recommendation: HOLD

Number of FII/FPI investors decreased from 85 to 78 in Dec 2024 qtr

Abbott India Ltd.

10 Aug 2023

29077.40

-2.78%

Growth pace accelerating

Buy: Abbott India Ltd.

Target

ICICI Securities Limited

Abbott India (Abbott) continues to fare better than its MNC peers who are struggling for growth in line with the market rate for last couple of quarters. In Q1FY24, Abbott grew 13.4% ahead of the market growth of 9% despite mandated price cut on NLEM products (26% of core portfolio sales).

Abbott India Ltd. is trading below its 30 day SMA of 30284.4

Abbott India Ltd.

22 May 2023

29077.40

-2.78%

Rising above the challenges

Buy: Abbott India Ltd.

Recommendation Target

ICICI Securities Limited

Abbott India (Abbott) has been a consistent performer. Its strong set of brands has helped it report a YoY revenue growth for the last 22 quarters and heckled challenges like competition in existing brands, mandated price cuts. Despite being an MNC, Abbott has served to the local needs better by launching line extensions and entering new therapies.

Abbott India Ltd. is trading above its 200 day SMA of 28649.0

Abbott India Ltd.

22 May 2023

29077.40

-2.78%

Result Update:Abbott India

Hold: Abbott India Ltd.

Recommendation Target

Axis Direct

Company Outlook & Guidance: In last 2 quarters, company' growth has moderated and gross margins also has decresed due to higher proportion from Antidiabetic segment.Current Valuation: PE40x for FY25 earnings (Earlier Valuation:PE40x)